Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SHLS | 0.01% | $554.97M | -70.83% | 0.00% |
TAP | 0.05% | $12.33B | -9.59% | 2.93% |
HOLX | 0.06% | $13.86B | -18.85% | 0.00% |
FIZZ | -0.06% | $3.89B | -9.95% | 0.00% |
LMT | -0.06% | $105.15B | -1.34% | 2.88% |
MNR | -0.07% | $1.84B | -19.43% | 17.62% |
KMB | -0.08% | $47.17B | +10.42% | 3.45% |
BMY | -0.08% | $124.10B | +15.10% | 3.96% |
MRK | -0.08% | $226.74B | -31.48% | 3.52% |
ACCD | -0.11% | $572.31M | -31.10% | 0.00% |
NCLH | -0.12% | $8.34B | -9.46% | 0.00% |
SUI | -0.12% | $16.41B | +2.55% | 2.91% |
ITCI | 0.12% | $14.05B | +93.23% | 0.00% |
PRI | -0.13% | $9.46B | +12.91% | 1.26% |
TRI | 0.13% | $77.77B | +11.26% | 1.28% |
BLCO | -0.14% | $5.11B | -15.01% | 0.00% |
IMNN | 0.16% | $15.35M | -45.60% | 0.00% |
EAT | 0.16% | $6.62B | +192.48% | 0.00% |
GEN | 0.16% | $16.36B | +18.96% | 1.89% |
ASUR | -0.22% | $257.65M | +26.66% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 42.73% | $5.33B | 0.35% |
GNOM | 40.77% | $53.29M | 0.5% |
IBB | 38.33% | $5.92B | 0.45% |
ARKG | 36.99% | $977.87M | 0.75% |
IWC | 36.40% | $810.14M | 0.6% |
CPRJ | 34.02% | $48.46M | 0.69% |
HYGV | 33.59% | $1.41B | 0.37% |
PBE | 33.55% | $233.11M | 0.58% |
KJAN | 32.80% | $318.03M | 0.79% |
SCYB | 32.49% | $1.00B | 0.03% |
DFEM | 32.41% | $4.84B | 0.39% |
AOM | 32.40% | $1.45B | 0.15% |
HYDB | 32.12% | $1.63B | 0.35% |
AVEM | 32.10% | $7.78B | 0.33% |
DRIV | 32.02% | $300.17M | 0.68% |
HYG | 31.97% | $15.11B | 0.49% |
ESGE | 31.95% | $4.50B | 0.26% |
AOK | 31.90% | $625.56M | 0.15% |
DFAE | 31.72% | $5.24B | 0.35% |
IEMG | 31.68% | $83.41B | 0.09% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RCKT | 40.97% | $711.22M | -75.04% | 0.00% |
CRSP | 40.80% | $2.92B | -50.09% | 0.00% |
RGNX | 38.72% | $358.12M | -66.79% | 0.00% |
CMPS | 38.02% | $196.06M | -70.45% | 0.00% |
DNLI | 37.64% | $1.97B | -33.88% | 0.00% |
ACLX | 36.98% | $3.60B | -2.06% | 0.00% |
OCUL | 36.37% | $1.17B | -15.65% | 0.00% |
RCKY | 36.13% | $129.62M | -36.63% | 3.62% |
VYGR | 35.61% | $186.60M | -67.93% | 0.00% |
DNTH | 35.19% | $582.75M | -38.96% | 0.00% |
ARWR | 34.89% | $1.75B | -54.89% | 0.00% |
NTLA | 34.82% | $736.01M | -73.88% | 0.00% |
ALLO | 34.55% | $317.21M | -66.67% | 0.00% |
IOVA | 34.19% | $1.09B | -76.53% | 0.00% |
SYRE | 34.11% | $972.25M | -56.39% | 0.00% |
KALV | 33.83% | $573.72M | +1.23% | 0.00% |
IMNM | 33.48% | $585.18M | -69.56% | 0.00% |
KYMR | 33.42% | $1.78B | -30.57% | 0.00% |
LGND | 33.04% | $2.02B | +42.85% | 0.00% |
MG | 33.03% | $328.32M | +9.41% | 0.00% |
Finnhub
LONDON, April 01, 2025 -- Autolus Therapeutics plc , an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies,...
Yahoo
Autolus Therapeutics PLC (AUTL) reports significant cash reserves and strategic advancements despite increased operational expenses.
Yahoo
Q4 2024 Autolus Therapeutics PLC Earnings Call
SeekingAlpha
Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Conference Call March 20, 2025 8:30 AM ETCompany ParticipantsAmanda Cray - IRChristian Itin - CEORob...
Yahoo
AUCATZYL® (obecabtagene autoleucel) U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024Obe-cel MHRA and EMA marketing authorizations expected in H2 2025Initial six patients dosed in Phase 1 dose confirmation trial in Systemic Lupus Erythematosus (SLE) Company to provide clinical development program updates, including plans for expansion in autoimmune diseases, at R&D investor event to be held on Apri
Finnhub
PDF Version AUCATZYL® U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024 ...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MO | -15.47% | $101.47B | +38.87% | 6.74% |
CBOE | -14.97% | $23.69B | +24.42% | 1.08% |
PRA | -12.20% | $1.19B | +82.99% | 0.00% |
VHC | -12.03% | $31.32M | +18.43% | 0.00% |
UUU | -11.55% | $4.12M | +11.25% | 0.00% |
K | -11.44% | $28.48B | +44.57% | 2.75% |
CHD | -11.44% | $27.09B | +4.83% | 1.03% |
KO | -11.01% | $308.22B | +18.03% | 2.74% |
KDP | -10.95% | $46.43B | +9.57% | 2.59% |
HUSA | -10.94% | $12.08M | -45.38% | 0.00% |
XEL | -10.86% | $40.67B | +32.86% | 3.13% |
ETR | -10.77% | $36.83B | +63.24% | 4.75% |
PGR | -10.64% | $165.90B | +34.80% | 1.73% |
PRT | -10.60% | $52.31M | +2.63% | 10.40% |
PEP | -10.01% | $205.64B | -13.32% | 3.60% |
T | -9.94% | $203.00B | +61.60% | 3.91% |
PAYC | -9.72% | $12.51B | +10.19% | 0.69% |
YOU | -9.24% | $2.51B | +25.65% | 1.73% |
KVUE | -9.20% | $45.83B | +12.95% | 3.39% |
UTZ | -8.86% | $1.21B | -24.20% | 1.69% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPMN | -0.06% | $33.51M | 0.65% |
CCOR | -0.17% | $64.35M | 1.18% |
IEO | 0.28% | $559.60M | 0.4% |
FTXG | -0.36% | $25.74M | 0.6% |
XLE | 0.47% | $32.78B | 0.09% |
FTXN | 0.52% | $155.55M | 0.6% |
DBA | 0.66% | $822.16M | 0.93% |
FSTA | 0.68% | $1.26B | 0.084% |
RSPG | 0.75% | $507.19M | 0.4% |
JMST | 0.75% | $3.55B | 0.18% |
GOVZ | 0.77% | $288.61M | 0.1% |
FMHI | 0.82% | $777.09M | 0.7% |
CLOA | -0.86% | $786.72M | 0.2% |
IYE | 0.94% | $1.30B | 0.39% |
EQLS | -0.95% | $4.77M | 1% |
XLP | -0.96% | $16.50B | 0.09% |
ICLO | -1.00% | $354.53M | 0.2% |
DRLL | 1.05% | $299.17M | 0.41% |
AMLP | -1.06% | $10.87B | 0.85% |
MLPX | 1.10% | $2.77B | 0.45% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -25.45% | $404.97M | 1.43% |
UUP | -20.42% | $327.80M | 0.77% |
USDU | -20.03% | $213.46M | 0.5% |
VIXY | -17.83% | $195.31M | 0.85% |
TAIL | -10.87% | $86.92M | 0.59% |
UGA | -9.52% | $88.11M | 0.97% |
ETH | -8.26% | $1.29B | 0% |
USL | -8.26% | $46.60M | 0.85% |
DBO | -7.82% | $197.54M | 0.77% |
USO | -7.81% | $1.02B | 0.6% |
OILK | -7.81% | $66.42M | 0.69% |
BNO | -7.66% | $95.40M | 1% |
DBE | -7.57% | $54.58M | 0.77% |
MINT | -6.41% | $13.27B | 0.35% |
IYK | -5.31% | $1.50B | 0.4% |
JBBB | -5.13% | $1.74B | 0.49% |
AGZD | -4.15% | $136.29M | 0.23% |
CTA | -3.66% | $963.19M | 0.76% |
WEAT | -3.58% | $113.78M | 0.28% |
JUCY | -3.08% | $305.86M | 0.6% |
Current Value
$1.571 Year Return
Current Value
$1.571 Year Return